Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

Medpace Holdings Price Quote

$341.66
-0.29 (-0.08%)
(Updated: December 11, 2024 at 5:55 PM ET)

Medpace Holdings Key Stats

Buy
51
Medpace Holdings (MEDP) is a Buy

Day range:
$341.43 - $354.75
52-week range:
$277.72 - $459.77
Dividend yield:
0%
P/E ratio:
38.51
P/S ratio:
5.28
P/B ratio:
12.06%

Volume:
305.5K
Avg. volume:
339.7K
1-year change:
20.75%
Market cap:
$10.6B
Revenue:
$1.9B
EPS:
$11.42

How Much Does Medpace Holdings Make?

Is Medpace Holdings Growing As A Company?

  • What Is Medpace Holdings's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Medpace Holdings's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.36%

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went down by -5.74% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 20.75% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Is It Risky To Buy Medpace Holdings?

  • How Much Debt Does Medpace Holdings Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medpace Holdings Have?
    Cash and short term investments quarterly total is $656.9M
  • What Is Medpace Holdings’s Book Value Per Share?
    Book value per share is 28.36

Is Medpace Holdings Cash Flow Positive?

  • What Is MEDP Cash Flow From Operations?
    Cash flow from operations (TTM) is $574.5M
  • What Is Medpace Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $16.1M
  • What Is Medpace Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$28.7M

Medpace Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    MEDP return on invested capital is 54.64%
  • What Is Medpace Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is 20.44%
  • What Is MEDP Return On Equity?
    ROE is a measure of profitability and is 54.64%

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • Fortrea Holdings Inc (FTRE)
    • IGC Pharma Inc (IGC)
    • IQVIA Holdings Inc (IQV)

Medpace Holdings Dividend Yield

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 35.59% 5.15%
Revenue: 8.29% -1.42%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 347.92
Upside from Last Price: 1.75%

Major Shareholders

  • How many MEDP shares are owned by institutional investors?
    37.3M MEDP shares are owned by institutional investors
  • How many MEDP shares are owned by insiders?
    801.3K MEDP shares are owned by insiders